Connectivity Software from Jungo to be Demonstrated at CeBIT 2011
- Comprehensive suite of embedded USB, WiFi and Bluetooth software, driver development tools to be demonstrated
- Featuring full support for the new USB 3.0 protocol
Jungo Ltd ., a leading provider of connectivity stacks and driver development tools, will be demonstrating its comprehensive range of embedded connectivity software, driver platforms and industry-specific solutions at the CeBIT 2011 conference and exhibition, in Hanover, Germany. The Jungo booth will demonstrate the company’s full support for the new USB 3.0 protocol.
Jungo’s connectivity software can be found in over 700 million devices worldwide and in industries as diverse as mobile phones, broadband modems, point-of-sale, medical equipment, defense industries, the automotive industry and digital TV. Jungo’s driver development tools and embedded stacks for major connectivity protocols enable manufacturers to focus on their core business and to bring their products to market swiftly and cost-effectively.
On their stand at CeBIT, Jungo will showcase embedded stacks for USB (USBware) and Bluetooth (BTware), PC USB class drivers (DriverCore) and the PC driver development toolkit (WinDriver).
Industry-specific solutions to be displayed include middleware for in-car infotainment systems, a comprehensive software suite for connecting automotive infotainment to smartphones, media players and other devices, and specialized solutions for the Broadband Mobile and Digital TV markets.
“Jungo’s deep understanding of connectivity software and our track record of delivering timely solutions make us the choice of industry-leading chip manufacturers, device manufacturers and OEMs in North America, Europe and the Asia-Pacific region,” said Ophir Herbst General Manager of Jungo Connectivity. “Our market leadership is demonstrated once again by our full support for the new USB 3.0 protocol.”
The Jungo booth will be in the USB-IF zone, in Hall 17, Stand D76, at CeBIT.
About Jungo
Jungo Ltd., an NDS Group company, is a provider of broadband home value-added service solutions. Jungo's flagship products, OpenRG™ (residential gateway software platform) and OpenSMB™ (small and medium business gateway software platform) enable broadband operators to deliver managed revenue-generating services to the digital home.
Jungo also offers a variety of connectivity software solutions for USB and PCI. These include WinDriver™, a driver development toolkit that enables developers to create custom device drivers that can run on a multitude of operating systems without modification.
DriverCore™ offers standard USB drivers, allowing device manufacturers to expose a variety of native communication interfaces via USB to different operating systems and platforms. USBware™ is a complete, high quality and small footprint embedded USB software protocol stack, allowing device manufacturers to incorporate standard USB connectivity easily in their designs.
MediaCore™ enables automotive infotainment systems manufacturers to integrate a complete hardware and media access, control and streaming infrastructure into their products.
To find out more about Jungo, visit www.jungo.com
Contact:
To book a meeting:
Jungo Ltd.
Yuval Ben-Zeev
Sales
Manager
T: +972.74 7212111
yuvalb@jungo.com
or
For
further information:
Jungo Ltd.
Daphna Weiss
Manager,
Marketing Communications
T: +972.74 7212121
daphna@jungo.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Receives Marketing Clearance for Lumipulse®G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease17.5.2025 08:58:00 CEST | Press release
—First Blood-Based In-Vitro Diagnostic Test to Receive FDA Clearancefor Patients Being Assessed for Alzheimer’s Disease. ——Availability of Accurate, Accessible, Blood-Based Diagnostic Tests Will Aid in Development and Availability of More Effective Interventions for Alzheimer’s Disease — Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an estimated 7.2 million Americans, a number projected to rise to nearly 14 million by 2060.1 It is a leading cause
IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes16.5.2025 23:17:00 CEST | Press release
IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050
Origins Launches in the U.S. Amazon Premium Beauty Store16.5.2025 15:00:00 CEST | Press release
The brand brings its high-performance, clinically proven, nature-inspired skincare to Amazon shoppers Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516435958/en/ This launch marks a strategic step in Origins’ ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy a
The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow16.5.2025 12:47:00 CEST | Press release
Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 professionals from 157 nations took the opportunity to connect, initiate partnerships and launch new projects. The accompanying conferences and side events also attracted strong interest, drawing more than 2,600 participants. The message sent out by The smarter E Europe and its four exhibitions – Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe – was clear: We are the energy system. This press release features multimedia. View the full release here: https://www.businesswire.c
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes16.5.2025 12:30:00 CEST | Press release
IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025 Notes Series Tender Cap and the 2040 Notes Series Tender Cap (each as defined below) remain unchanged at $500,000,000 and $450,000,000, respectively. Details of tender offers IFF initially offered to purchase for cash: (i) up to $1,000,000,000 aggregate purchase price, excluding accrued and unpaid in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom